Literature DB >> 9246058

Tachykinins stimulate lipid peroxidation mediated by free radicals in gastrointestinal tract of rat.

M Lördal1, O Söder, P M Hellström.   

Abstract

Tissue concentrations of malondialdehyde in the gastrointestinal tract of the rat were quantified as indicators of lipid peroxidation and tissue damage after challenge with tachykinins and after pretreatment with allopurinol. Neurokinin A, neurokinin B, and substance P given intravenously during 30 min increased the production of malondialdehyde in the stomach, duodenum, jejunum, and colon in a dose-dependent manner at doses from 100 to 400 pmol/kg/min (P < 0.05-0.01). However, the stomach seemed less responsive to the tachykinin challenge. For comparison, a similar dose-dependent increase of malondialdehyde was found in the liver and lung, with more pronounced effects of neurokinin B (P < 0.05-0.01). Pretreatment with allopurinol, 10 mg/kg, significantly reduced malondialdehyde responses to tachykinin challenge in intestinal tissues (P < 0.001). In conclusion, elaboration of malondialdehyde is suggested to reflect the ability of gastrointestinal tissues to react to tachykinins at high concentrations with liberation of free radicals as part of an inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246058     DOI: 10.1023/a:1018835314834

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

Review 1.  New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization.

Authors:  D Regoli; N E Rhaleb; S Dion; G Drapeau
Journal:  Trends Pharmacol Sci       Date:  1990-04       Impact factor: 14.819

Review 2.  Prooxidant states and tumor promotion.

Authors:  P A Cerutti
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

Review 3.  Mechanisms of cell death.

Authors:  A R Boobis; D J Fawthrop; D S Davies
Journal:  Trends Pharmacol Sci       Date:  1989-07       Impact factor: 14.819

4.  Substance P release from spinal cord slices by capsaicin.

Authors:  R Gamse; A Molnar; F Lembeck
Journal:  Life Sci       Date:  1979-08-13       Impact factor: 5.037

5.  Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors.

Authors:  S Brunelleschi; L Vanni; F Ledda; A Giotti; C A Maggi; R Fantozzi
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

6.  Spin trapping of free radicals produced in vivo in heart and liver during endotoxemia.

Authors:  D J Brackett; E K Lai; M R Lerner; M F Wilson; P B McCay
Journal:  Free Radic Res Commun       Date:  1989

Review 7.  Tachykinin and calcitonin gene-related peptide immunoreactivities and mRNAs in the mammalian enteric nervous system and sensory ganglia.

Authors:  C Sternini
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

8.  Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig.

Authors:  X Y Hua; E Theodorsson-Norheim; E Brodin; J M Lundberg; T Hökfelt
Journal:  Regul Pept       Date:  1985-12

9.  A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig.

Authors:  J M Lundberg; A Saria; E Brodin; S Rosell; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Antisera raised against eledoisin and kassinin detect immunoreactive material in rat tissue extracts: tissue distribution and chromatographic characterization.

Authors:  E Theodorsson-Norheim; E Brodin; I Norheim; S Rosell
Journal:  Regul Pept       Date:  1984-11
View more
  1 in total

1.  Substance P failed to reverse dextran sulfate sodium-induced murine colitis mediated by mitochondrial dysfunction: implications in ulcerative colitis.

Authors:  Spoorthi B Chandraiah; Shashwati Ghosh; Ishita Saha; Sunil S More; Gautham S Annappa; Arpan K Maiti
Journal:  3 Biotech       Date:  2021-03-29       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.